Enalare Therapeutics - Ownership and Business Overview

Life ScienceCompany

Enalare Therapeutics Ownership

Who owns Enalare Therapeutics?

.

Enalare Therapeutics Business Overview

Where is Enalare Therapeutics headquartered?

Enalare Therapeutics is headquartered in Princeton, New Jersey.

What sector is Enalare Therapeutics in?

Enalare Therapeutics is a life science company.

Life Science M&A Summary in

Join Mergr to view all 0 acquisitions of life science companies in , including .

Enalare Therapeutics

Enalare Therapeutics, Inc.

161 Hodge Road,
Princeton, New Jersey 08540
United States,
www.enalare.com

Enalare Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients suffering from life-threatening acute respiratory and critical care conditions, including community drug overdose, postoperative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, New Jersey.


 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.